DXCM
Dexcom Inc
MEDICAL DEVICES · HEALTHCARE
DexCom, Inc. is a prominent leader in diabetes management, renowned for its state-of-the-art continuous glucose monitoring (CGM) systems that empower patients to optimize their glucose levels effectively. Based in San Diego, California, with a manufacturing facility in Mesa, Arizona, the company is ...
$71.44
+6.71% (+$4.49)
Volume
11.24M
52W High
$89.98
52W Low
$54.11
Market Cap
$22.52B
Next Earnings Report
Last Reported
Apr 30, 2026 Beat
Actual: $0.56
vs. Consensus: $0.47
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
Apr 30, 2026
1-Day:
+3.02%
5-Day:
-0.12%
Q1 2026
Apr 23, 2026
1-Day:
-1.80%
5-Day:
-5.39%
Q4 2025
Feb 12, 2026
1-Day:
+7.59%
5-Day:
+8.22%
Q4 2025
Feb 5, 2026
1-Day:
+0.11%
5-Day:
-2.48%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $1.26B | +13.1% | 62.9% | 25.6% | $267.3M |
| Q3'25 | $1.21B | +21.6% | 60.5% | 20.1% | $283.8M |
| Q2'25 | $1.16B | +15.2% | 59.5% | 18.4% | $179.8M |
| Q1'25 | $1.04B | +12.5% | 56.9% | 12.9% | $105.4M |
| Q4'24 | $1.11B | +7.6% | 58.9% | 17.0% | $151.7M |
| Q3'24 | $994.2M | +2.0% | 59.7% | 15.3% | $134.6M |
| Q2'24 | $1.00B | +15.3% | 62.4% | 15.7% | $143.5M |
| Q1'24 | $921.0M | +24.2% | 61.0% | 11.0% | $146.4M |
Company Information
Symbol
DXCM
Company
Dexcom Inc
Market Cap
$22.52B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in MEDICAL DEVICES
Compare DXCM with competitors
Side-by-side earnings comparison